How to Start a Peptide Therapy Program at Your Practice

Starting a peptide therapy program requires a state medical license with prescriptive authority, a relationship with a licensed 503A or 503B compounding pharmacy, HIPAA-compliant documentation systems, and proper informed consent protocols. Most practices can launch within 60 to 90 days by starting with one or two high-demand peptides like BPC-157 or a growth hormone secretagogue stack, establishing a clear patient intake workflow, and building compliance infrastructure before marketing. The peptide therapeutics market reached $140 billion in 2025 and continues growing at nearly 9% annually, creating significant revenue opportunities for practices that approach the space correctly.

This guide walks through each step of launching a peptide program: the credentials you need, which peptides make sense for a new program, how to source from compounding pharmacies, patient workflows, compliance requirements, lab protocols, marketing approaches, and realistic cost expectations.

What Are the Minimum Requirements to Offer Peptide Therapy?

Before ordering your first vial, you need the right credentials and infrastructure in place.

Prescriptive Authority

Peptide prescribing authority depends on your professional license and state regulations. The following practitioners can typically prescribe peptide therapies:

• Physicians (MD/DO) with an active state license
• Nurse practitioners with prescriptive authority (scope varies by state)
• Physician assistants under collaborative agreement
• Naturopathic doctors in states that grant prescriptive authority

In states with full practice authority, NPs can independently prescribe peptide therapies without physician oversight. PAs typically need a collaborative agreement, though specifics vary. Check your state medical board's regulations before proceeding.

Training and Certification

While not legally required in most states, peptide therapy certification strengthens your clinical knowledge and liability position. Major programs include:

A4M/MMI Peptide Therapy Certification: Offered through George Washington University School of Medicine, this program provides up to 20.5 AMA PRA Category 1 credits. Requires A4M or International Peptide Society membership.

Empire Medical Training: AMA-accredited courses covering pharmacology, clinical protocols, and practice development. Includes FDA classification guidance and compliant prescribing practices.

My Practice Connect: Focuses on practical implementation with consent forms, intake templates, and protocol documentation.

Certificates typically require renewal every two years given how quickly regulations and research evolve.

Business Requirements

You will need:

• Professional liability insurance covering peptide therapies (some carriers exclude them)
• DEA registration (not typically required for peptides, but verify for your specific offerings)
• State pharmacy board compliance for any in-office dispensing
• HIPAA-compliant EHR and communication systems
• Business associate agreements with compounding pharmacies and labs

Which Peptides Should You Start With?

The common advice is correct: start with one or two peptides and expand from there. This approach lets you build expertise, refine your workflow, and develop targeted marketing.

High-Demand Starting Options

For practices focusing on weight management: Semaglutide and tirzepatide compounded formulations have the strongest patient demand. These GLP-1 receptor agonists have robust clinical evidence and name recognition from branded versions. Be aware that regulatory status changes frequently. The FDA ended compounding exemptions for semaglutide in early 2025 when the drug shortage resolved, then later announcements shifted the landscape again.

For practices focusing on recovery and healing: BPC-157 (Body Protection Compound-157) returned to Category 1 status in February 2026, meaning licensed 503A compounding pharmacies can prepare it under physician prescription. Preclinical data is promising for tissue repair, though formal human trials remain limited.

For practices focusing on anti-aging and hormone optimization: The CJC-1295 + Ipamorelin stack is a standard growth hormone secretagogue combination. Tesamorelin has FDA approval for HIV-associated lipodystrophy and sees off-label use for visceral fat reduction.

Commonly Prescribed Peptides in 2026

Regulatory Considerations

The February 2026 HHS announcement reclassified 14 previously restricted peptides from Category 2 to Category 1, expanding what 503A pharmacies can compound. However, state-level variation persists. Federal Category 1 status does not automatically satisfy state-level rules.

Before adding any peptide, verify:

• FDA approval status
• Whether your use is on-label, off-label, or investigational
• State-specific restrictions on experimental therapies
• State scope of practice and supervision requirements

How Do You Set Up Compounding Pharmacy Relationships?

Your compounding pharmacy relationship is one of the most important decisions you will make. Quality, reliability, and compliance vary significantly across providers.

503A vs 503B: Understanding the Difference

503A Compounding Pharmacies:

• Prepare patient-specific medications based on individual prescriptions
• Primarily regulated by state boards of pharmacy
• Must comply with USP 797 and 800 standards
• Cannot compound without a patient-specific prescription
• Cannot ship across state lines (with some exceptions)

503B Outsourcing Facilities:

• Can prepare medications without patient-specific prescriptions
• Subject to FDA inspection and CGMP (current good manufacturing practices)
• Can ship nationwide
• Held to higher regulatory standards
• Can provide office-use stock for qualifying practices

For most practices starting peptide programs, 503A pharmacies offer the right fit. They handle individualized prescriptions and work directly with your patient workflow. 503B facilities make more sense if you need ready-to-dispense inventory or operate at higher volume.

What to Look for in a Compounding Pharmacy

Evaluate potential pharmacy partners on:

Regulatory compliance: Current USP 797 compliance, robust environmental monitoring, and third-party analytical testing distinguish quality operators. Ask about their compliance posture following the April 2026 FDA guidance.

Certificates of Analysis (COAs): Every compounded peptide should come with a COA showing purity testing, identity verification, and potency. Request samples of recent COAs before committing.

Turnaround time: Patient experience suffers if prescriptions take two weeks to fill. Understand typical fulfillment timelines and shipping options.

Clinical support: Some pharmacies provide dosing guidelines, patient education materials, and clinical consultation. This support helps when you are building your protocols.

Pricing structure: Wholesale costs typically run 50% to 85% of your patient pricing depending on volume and peptide type. Negotiate based on projected volume.

Establishing the Relationship

Contact pharmacy compliance or provider relations departments directly. Expect to provide:

• Copy of medical license
• DEA registration (if applicable)
• Business license and tax ID
• Completed provider application
• Signed business associate agreement

Most pharmacies can onboard new prescribers within one to two weeks.

What Does the Patient Workflow Look Like?

A clear patient workflow protects your practice, sets appropriate expectations, and creates a consistent experience.

Step 1: Initial Screening and Intake

Capture comprehensive information before the consultation:

• Medical history (conditions, surgeries, hospitalizations)
• Current medications and supplements
• Allergies and adverse reactions
• Family history relevant to peptide use (cancer history, cardiovascular disease)
• Treatment goals and expectations
• Insurance information (most peptide therapy is cash-pay)

Use digital intake forms that integrate with your EHR. This saves chair time and ensures complete documentation.

Step 2: Baseline Laboratory Testing

Order relevant labs before prescribing. A typical baseline panel includes:

• Complete blood count (CBC)
• Comprehensive metabolic panel (CMP)
• Fasting glucose and HbA1c
• Lipid panel
• IGF-1 (essential for growth hormone secretagogues)
• Hormone panel: testosterone, estradiol, thyroid function (TSH, free T4, free T3)
• Inflammatory markers: hs-CRP
• Liver enzymes: ALT, AST

Lab costs run $150 to $400 cash-pay depending on the panel. Some practices include baseline labs in their program fee.

Step 3: Clinical Consultation

During the consultation:

• Review intake forms and lab results
• Assess suitability for peptide therapy
• Discuss treatment options with risks and benefits
• Address patient questions
• Determine whether the patient is a good candidate

For telehealth consultations, verify state prescribing requirements. Some states require an in-person examination before prescribing compounded peptides. Others accept telehealth encounters.

Step 4: Informed Consent

Informed consent is not optional. Your consent documentation should include:

• Peptide name, source, lot number, route, and dose
• Expected benefits and known risks
• Acknowledgment that the treatment may be off-label or use compounded medications
• Statement that compounded drugs do not undergo FDA premarket review
• Potential unknowns about long-term safety
• Alternative treatment options
• Patient's right to withdraw consent

Keep signed consent forms in the patient record. Document that the consent discussion occurred.

Step 5: Prescription and Fulfillment

Send prescriptions to your compounding pharmacy partner. Most pharmacies can:

• Ship directly to patients
• Provide tracking information
• Include administration instructions
• Supply necessary supplies (syringes, alcohol swabs, bacteriostatic water)

Confirm patients receive their medications and understand reconstitution and administration procedures.

Step 6: Follow-Up and Monitoring

Schedule follow-up appointments:

• 4 to 8 weeks: Initial response assessment, side effect check
• 3 months: Lab recheck, dosage adjustment if needed
• 6 months: Comprehensive review
• Ongoing: Quarterly or biannual monitoring

Document outcomes, adjust protocols, and maintain ongoing communication. Practices that build follow-up into their workflow see better retention and outcomes.

How Do You Handle EHR and HIPAA Compliance?

Peptide therapy creates the same HIPAA obligations as any other medical service, but the cash-pay nature and telehealth components add complexity.

EHR Requirements

Your EHR system must support:

• Unique user access controls: Shared login credentials violate HIPAA access control standards
• Audit trails: Track who accessed what records and when
• Data encryption: Both in transit and at rest
• Secure messaging: HIPAA-compliant patient communication
• E-prescribing integration: Direct connection to compounding pharmacies

If your current EHR cannot handle these requirements, consider platforms built for integrative and cash-pay practices. OptiMantra, Healthie, and similar systems offer peptide-specific workflows.

Business Associate Agreements

Execute BAAs with:

• EHR vendors
• Compounding pharmacies
• Laboratory partners
• Telehealth platforms
• Payment processors
• Any cloud storage providers

Without a signed BAA, sharing protected health information with these entities creates a HIPAA violation.

Documentation Standards

Maintain complete records including:

• Patient intake and medical history
• Lab orders and results
• Consultation notes
• Informed consent (signed)
• Prescriptions issued
• Follow-up notes
• Adverse event documentation

Charts should demonstrate medical necessity for peptide therapy and show that informed consent was obtained.

Telehealth Considerations

If offering virtual consultations:

• Use a HIPAA-compliant video platform
• Verify patient identity at each visit
• Document the telehealth encounter format
• Confirm prescribing is legal in the patient's state
• Maintain records of technical aspects (platform used, connection quality)

What Lab Testing Do Patients Need?

Laboratory monitoring protects patients and demonstrates clinical rigor.

Baseline Testing

Before starting any peptide protocol, establish baselines for:

Ongoing Monitoring

Follow-up testing depends on the peptide prescribed:

Growth hormone secretagogues (CJC-1295, Ipamorelin, Sermorelin):

• IGF-1 every 3 to 6 months
• Fasting glucose and HbA1c every 3 to 6 months
• Lipid panel every 6 to 12 months

GLP-1 agonists (Semaglutide, Tirzepatide):

• HbA1c every 3 months initially
• Renal function monitoring
• Lipase if GI symptoms develop

General monitoring for all peptides:

• Liver enzymes if baseline abnormalities
• CBC if fatigue or unusual symptoms
• Follow-up based on clinical findings

Adjust testing frequency based on patient response and any adverse effects. Document all lab orders and review processes in the chart.

How Do You Market Peptide Services to Patients?

Marketing peptide therapy requires an education-first approach and careful attention to compliance.

Regulatory Restrictions on Marketing

Peptides are among the most restricted categories in digital advertising. Key constraints:

• Cannot advertise peptides by name in paid ads on most platforms
• Cannot make direct medical claims about unapproved uses
• Meta and Google routinely ban accounts for peptide-related violations
• FTC regulations apply to health claims

Work with marketing agencies experienced in peptide and longevity spaces, or expect to lose advertising accounts.

What You Can Market

Focus on outcomes rather than specific products:

• "Medical weight management programs"
• "Recovery and healing optimization"
• "Hormone health services"
• "Anti-aging and longevity medicine"

Once patients inquire, education happens in the consultation setting.

Effective Marketing Channels

SEO and content marketing: Target buyer-intent keywords. Create educational content about the conditions you treat. Build authority over time.

Existing patient base: Your current patients are the warmest leads. Use in-office signage, provider conversations, and email newsletters to introduce peptide services.

Referral programs: Satisfied peptide patients refer friends. Encourage and track referrals.

Local search optimization: Claim and optimize your Google Business Profile. Target local keywords like "peptide therapy [city]."

Consultation funnels: Drive inquiries toward consultations rather than product pages. Peptide therapy is best explained through conversation.

Setting Patient Expectations

Be clear about:

• What FDA approval means (and does not mean)
• The difference between compounded and branded medications
• Realistic timelines for results
• Ongoing monitoring requirements
• Out-of-pocket costs

Overpromising creates liability and disappointment. Underpromise and overdeliver.

What Will This Cost to Launch?

Startup costs vary dramatically based on your existing infrastructure and how you structure the program.

Minimal Launch (Adding to Existing Practice)

If you already have a functioning practice with EHR, staff, and patient flow:

You can start prescribing peptides with minimal additional investment if your practice infrastructure supports it.

Full Peptide Clinic Build-Out

A dedicated peptide and longevity clinic from scratch involves significantly more capital:

Revenue Potential

Pricing for peptide programs typically runs $150 to $400 per month depending on the protocol, consultation frequency, and lab requirements. Mark-up potential ranges from 50% to 200% over cost.

Patient lifetime value increases with recurring protocols. A patient on a growth hormone secretagogue program for 12 months generates significantly more revenue than a single consultation.

Key Takeaways

• Start with one or two high-demand peptides and build expertise before expanding
• Verify your prescriptive authority and state-specific regulations before prescribing
• Partner with a compliant 503A or 503B compounding pharmacy that provides COAs
• Build informed consent and documentation into every patient interaction
• Use a HIPAA-compliant EHR with proper access controls and audit trails
• Order baseline labs and follow monitoring protocols for each peptide category
• Market outcomes and education, not specific product names

Frequently Asked Questions

Do I need special certification to prescribe peptides?

No specific certification is legally required in most states if you hold prescriptive authority. However, training programs from A4M, Empire Medical, and similar organizations strengthen your clinical knowledge and may reduce liability exposure.

Can nurse practitioners prescribe peptides independently?

In states with full practice authority, NPs can prescribe peptide therapies without physician oversight. Other states require collaborative agreements or supervision. Check your state board regulations.

What is the difference between 503A and 503B pharmacies?

503A compounding pharmacies prepare patient-specific medications based on individual prescriptions and are state-regulated. 503B outsourcing facilities can prepare medications without patient-specific prescriptions, are FDA-inspected, and can ship nationwide.

How long does it take to launch a peptide program?

Most practices can launch within 60 to 90 days. This includes completing training, establishing pharmacy relationships, developing protocols and consent forms, and initial marketing.

What peptides have the highest patient demand?

Weight management peptides (semaglutide, tirzepatide) see highest demand due to branded awareness. BPC-157 and growth hormone secretagogue stacks (CJC-1295 + Ipamorelin) are popular in recovery and anti-aging focused practices.

Conclusion

Launching a peptide therapy program represents a real opportunity for practices looking to expand into longevity, weight management, and regenerative medicine. The market continues growing, patient awareness is increasing, and regulatory clarity improved with recent FDA guidance.

Success requires doing the work upfront: proper training, compliant pharmacy relationships, robust documentation, and patient-centered workflows. Practices that approach peptide therapy as serious medicine rather than a quick revenue play will build sustainable programs and protect their licenses.

Start small, document everything, and expand as your expertise grows.

This content is for informational purposes only and does not constitute medical advice. Consult with a healthcare attorney and compliance specialist before launching peptide therapy services. Regulatory status of specific peptides changes frequently.

Sources

• OptiMantra: How to Start a Peptide Program at Your Practice
• A4M Peptide Therapy Certification
• George Washington University Peptides Module
• Frier Levitt: Regulatory Status of Peptide Compounding in 2025
• The FDA Group: 503A vs. 503B Compounding Pharmacy Guide
• OptiMantra: Peptide Protocol Documentation Guide
• Clinical Peptide Society: Consent Form
• HealingMaps: Lab Work Before Peptide Therapy
• LIVV Natural: Lab Monitoring in Peptide Therapy
• OptiMantra: Peptide Therapy Marketing 2026
• OpenLoop Health: State of Peptide Market 2026
• PeptideDeck: How to Get Peptides Prescribed